Literature DB >> 12482972

Proteolytic cleavage of MLL generates a complex of N- and C-terminal fragments that confers protein stability and subnuclear localization.

James J-D Hsieh1, Patricia Ernst, Hediye Erdjument-Bromage, Paul Tempst, Stanley J Korsmeyer.   

Abstract

The mixed-lineage leukemia gene (MLL, ALL1, HRX) encodes a 3,969-amino-acid nuclear protein homologous to Drosophila trithorax and is required to maintain proper Hox gene expression. Chromosome translocations in human leukemia disrupt MLL (11q23), generating chimeric proteins between the N terminus of MLL and multiple translocation partners. Here we report that MLL is normally cleaved at two conserved sites (D/GADD and D/GVDD) and that mutation of these sites abolishes the proteolysis. MLL cleavage generates N-terminal p320 (N320) and C-terminal p180 (C180) fragments, which form a stable complex that localizes to a subnuclear compartment. The FYRN domain of N320 directly interacts with the FYRC and SET domains of C180. Disrupting the interaction between N320 and C180 leads to a marked decrease in the level of N320 and a redistribution of C180 to a diffuse nuclear pattern. These data suggest a model in which a dynamic post-cleavage association confers stability to N320 and correct nuclear sublocalization of the complex, to control the availability of N320 for target genes. This predicts that MLL fusion proteins of leukemia which would lose the ability to complex with C180 have their stability conferred instead by the fusion partners, thus providing one mechanism for altered target gene expression.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12482972      PMCID: PMC140678          DOI: 10.1128/MCB.23.1.186-194.2003

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  36 in total

1.  MLL and CREB bind cooperatively to the nuclear coactivator CREB-binding protein.

Authors:  P Ernst; J Wang; M Huang; R H Goodman; S J Korsmeyer
Journal:  Mol Cell Biol       Date:  2001-04       Impact factor: 4.272

2.  Novel human HALR (MLL3) gene encodes a protein homologous to ALR and to ALL-1 involved in leukemia, and maps to chromosome 7q36 associated with leukemia and developmental defects.

Authors:  Y C Tan; V T Chow
Journal:  Cancer Detect Prev       Date:  2001

3.  Association of SET domain and myotubularin-related proteins modulates growth control.

Authors:  X Cui; I De Vivo; R Slany; A Miyamoto; R Firestein; M L Cleary
Journal:  Nat Genet       Date:  1998-04       Impact factor: 38.330

4.  The amino terminus of the mixed lineage leukemia protein (MLL) promotes cell cycle arrest and monocytic differentiation.

Authors:  C Caslini; A Shilatifard; L Yang; J L Hess
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-14       Impact factor: 11.205

5.  Mammalian Trithorax and polycomb-group homologues are antagonistic regulators of homeotic development.

Authors:  R D Hanson; J L Hess; B D Yu; P Ernst; M van Lohuizen; A Berns; N M van der Lugt; C S Shashikant; F H Ruddle; M Seto; S J Korsmeyer
Journal:  Proc Natl Acad Sci U S A       Date:  1999-12-07       Impact factor: 11.205

6.  Protein interactions of the MLL PHD fingers modulate MLL target gene regulation in human cells.

Authors:  K Fair; M Anderson; E Bulanova; H Mi; M Tropschug; M O Diaz
Journal:  Mol Cell Biol       Date:  2001-05       Impact factor: 4.272

7.  A homeotic mutation in the trithorax SET domain impedes histone binding.

Authors:  K R Katsani; J J Arredondo; A J Kal; C P Verrijzer
Journal:  Genes Dev       Date:  2001-09-01       Impact factor: 11.361

8.  Tumorigenesis in mice with a fusion of the leukaemia oncogene Mll and the bacterial lacZ gene.

Authors:  C L Dobson; A J Warren; R Pannell; A Forster; T H Rabbitts
Journal:  EMBO J       Date:  2000-03-01       Impact factor: 11.598

9.  BCL-2, BCL-X(L) sequester BH3 domain-only molecules preventing BAX- and BAK-mediated mitochondrial apoptosis.

Authors:  E H Cheng; M C Wei; S Weiler; R A Flavell; T W Mak; T Lindsten; S J Korsmeyer
Journal:  Mol Cell       Date:  2001-09       Impact factor: 17.970

Review 10.  Molecular mechanisms of leukemogenesis mediated by MLL fusion proteins.

Authors:  P M Ayton; M L Cleary
Journal:  Oncogene       Date:  2001-09-10       Impact factor: 9.867

View more
  107 in total

Review 1.  The COMPASS family of histone H3K4 methylases: mechanisms of regulation in development and disease pathogenesis.

Authors:  Ali Shilatifard
Journal:  Annu Rev Biochem       Date:  2012       Impact factor: 23.643

2.  A pharmacologic inhibitor of the protease Taspase1 effectively inhibits breast and brain tumor growth.

Authors:  David Y Chen; Yishan Lee; Brian A Van Tine; Adam C Searleman; Todd D Westergard; Han Liu; Ho-Chou Tu; Shugaku Takeda; Yiyu Dong; David R Piwnica-Worms; Kyoung J Oh; Stanley J Korsmeyer; Ann Hermone; Richard Gussio; Robert H Shoemaker; Emily H-Y Cheng; James J-D Hsieh
Journal:  Cancer Res       Date:  2011-12-13       Impact factor: 12.701

3.  Hoxa9 and Meis1 are key targets for MLL-ENL-mediated cellular immortalization.

Authors:  Bernd B Zeisig; Tom Milne; María-Paz García-Cuéllar; Silke Schreiner; Mary-Ellen Martin; Uta Fuchs; Arndt Borkhardt; Sumit K Chanda; John Walker; Richard Soden; Jay L Hess; Robert K Slany
Journal:  Mol Cell Biol       Date:  2004-01       Impact factor: 4.272

4.  Ten members of the Arabidopsis gene family encoding methyl-CpG-binding domain proteins are transcriptionally active and at least one, AtMBD11, is crucial for normal development.

Authors:  Anita Berg; Trine J Meza; Mirela Mahić; Tage Thorstensen; Kjetil Kristiansen; Reidunn B Aalen
Journal:  Nucleic Acids Res       Date:  2003-09-15       Impact factor: 16.971

5.  Cleavage and proteasome-mediated degradation of the basal transcription factor TFIIA.

Authors:  Torill Høiby; Dimitra J Mitsiou; Huiqing Zhou; Hediye Erdjument-Bromage; Paul Tempst; Hendrik G Stunnenberg
Journal:  EMBO J       Date:  2004-07-15       Impact factor: 11.598

6.  ECSASB2 mediates MLL degradation during hematopoietic differentiation.

Authors:  Jingya Wang; Andrew G Muntean; Jay L Hess
Journal:  Blood       Date:  2011-12-15       Impact factor: 22.113

7.  Licensed to elongate: a molecular mechanism for MLL-based leukaemogenesis.

Authors:  Man Mohan; Chengqi Lin; Erin Guest; Ali Shilatifard
Journal:  Nat Rev Cancer       Date:  2010-09-16       Impact factor: 60.716

8.  Histone methyltransferase MLL1 regulates MDR1 transcription and chemoresistance.

Authors:  Hairong Huo; Pellegrino G Magro; E Christy Pietsch; Brijesh B Patel; Kathleen W Scotto
Journal:  Cancer Res       Date:  2010-09-22       Impact factor: 12.701

Review 9.  Throwing the cancer switch: reciprocal roles of polycomb and trithorax proteins.

Authors:  Alea A Mills
Journal:  Nat Rev Cancer       Date:  2010-10       Impact factor: 60.716

Review 10.  Menin, histone h3 methyltransferases, and regulation of cell proliferation: current knowledge and perspective.

Authors:  Xinjiang Wu; Xianxin Hua
Journal:  Curr Mol Med       Date:  2008-12       Impact factor: 2.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.